Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda

Friday, June 21, 2024

Ascentage Pharma a global biopharmaceutical company engaged in developing novel therapies for cancer chronic hepatitis B and agerelated diseases announced today that the agreed equity investment by Takeda

Johnson & Johnson Submits Application to U.S. FDA Seeking Approval of TREMFYA® (Guselkumab) for the Treatment of Moderately to Severely Active Crohn's Disease

Friday, June 21, 2024

Johnson Johnson today announced the submission of a supplemental Biologics License Application

Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies

Friday, June 21, 2024

Cryoport Inc a global leader in supply chain solutions for the life sciences and Minaris Regenerative Medicine Co Ltd a global contract development and manufacturing organization

GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group

Thursday, June 20, 2024

GC Cell a fully integrated cell and gene therapy pioneer is proud to announce the establishment of an MOU for strategic partnership with Bifarma a frontrunner in stem cell therapy within Indonesia with comprehensive capabilities

Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health

Thursday, June 20, 2024

Recently Professor Jianping Weng of the University of Science and Technology of China and President of Anhui Medical University and his team of researchers from USTC Southern Medical University

Medivir Selects Global CRO Partner for Upcoming Phase 2b Study in HCC With Fostrox + Lenvima and Initiates Study Feasibility

Thursday, June 20, 2024

Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that it has selected a global

YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China

Wednesday, June 19, 2024

YolTech a clinicalstage biopharmaceutical company specializing in mRNALNP delivery for in vivo gene editing therapies has partnered with KACTUS a leading developer serving the biopharmaceutical industry

Ability Biologics Announces Closing of US$18 Million Seed Funding to Generate Novel, Highly Targeted Immunomodulators

Wednesday, June 19, 2024

Ability Biologics announced the closing of its US million seed round a financing round led by Amplitude Ventures an investor founder of Ability The Fonds de solidarit FTQ Investissement Qubec

Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally

Wednesday, June 19, 2024

Singleron Biotechnologies announced a partnership with the Human Cell Atlas to help accelerate the adoption of single cell sequencing globally Singleron will facilitate access

magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024